Jun 17, 2025, 08:20 by

Key appointment to lead the company’s financial strategy and support continued global growth in sample stability and biorepository storage solutions

Jun 17, 2025, 08:20 by

ClearNote Health announced initiation of patient enrollment for a new study that aims to advance early detection of pancreatic cancer in individuals newly diagnosed with type 2 diabetes.

Jun 17, 2025, 01:00 by User Not Found

Clinical Research News | An artificial intelligence (AI) agent known as Grace is bringing clinical trials some much-needed speed and cost reduction and delivering more personalized, on-demand digital experiences for participants. Developed by fast-growing Grove AI, Grace has over the past year powered more than 50 phase 2 and 3 trials involving over 500,000 interactions with would-be and enrolled trial participants.

Jun 16, 2025, 08:11 by

Duke Street Bio has announced that the FDA has granted Fast Track designation to DSB2455, its next-generation, CNS-active selective PARP1 inhibitor.

Jun 12, 2025, 08:18 by

WCG proudly announces the winners of the first-ever prestigious WCG Pinnacle Award, Site Relationships. Award winners were chosen based on the results of WCG’s 2025 CenterWatch Global Site Relationship Survey that captured insights from more than 12,000 respondents.

Jun 12, 2025, 08:18 by

MIB Agents, a leading pediatric osteosarcoma nonprofit, announced it has awarded $2.5 million in research grants through its OutSmarting Osteosarcoma program, which is powered by families honoring children affected by the disease. At its upcoming FACTOR Conference (June 26–28) in Salt Lake City, the organization will award $700,000 in grants to 10 scientists advancing less toxic, more effective treatments. The grants, which include four $100,000 Hero Grants and six $50,000 Hope Young Investigator Grants, reflect a unique collaboration between researchers and the osteosarcoma community, with families actively funding and participating in the review of scientific proposals.

Jun 11, 2025, 09:38 by User Not Found

Clinical Research News | Today, IQVIA announced multiple AI orchestrator agents in collaboration with NVIDIA. These specialized agentic systems—covering trial start-up, target identification, clinical data review, and more—are designed to manage and accelerate drug development workflows for IQVIA customers.

Jun 11, 2025, 08:32 by

Ceryx Medical today announced the successful close of a new funding round, bringing the company’s total raised to $15 million.

Jun 11, 2025, 08:32 by

Published in Cell Metabolism, the Phenomix and Mayo Clinic research shows the MyPhenomeTM test can help providers guide obesity treatment by matching patients to GLP-1s or phentermine/topiramate based on their unique biology.

Jun 10, 2025, 08:44 by

Veloxity Labs has announced a new NIL (Name, Image and Likeness) partnership with Carolina Martinez, a standout sprinter at Bradley University and childhood cancer survivor. The collaboration reflects a shared commitment to science, community and purpose. Diagnosed with leukemia at age five, Carolina beat the odds—and now competes at the highest collegiate level, recently breaking a 41-year-old school record in the 300-meter dash. Her story of resilience and recovery deeply aligns with Veloxity’s mission: to accelerate therapeutic development and improve lives through high-quality, fast-turnaround bioanalytical testing. The partnership marks Veloxity’s first NIL collaboration and centers on the power of people-first science. Together, Veloxity and Carolina are sharing a message of hope and determination—most recently through a new commercial campaign filmed in Peoria.

Jun 10, 2025, 01:00 by User Not Found

Clinical Research News | Researchers have made a landmark discovery in rare disease clinical research by identifying a new subtype of Castleman disease, marking the first major advancement in disease classification since the 1970s. The breakthrough demonstrates how patient-driven research registries can overcome traditional barriers in rare disease studies to generate clinically meaningful insights.

Jun 6, 2025, 01:00 by User Not Found

Clinical Research News | Gastroenterology is seeing meaningful progress in clinical research. New therapies for inflammatory bowel disease, colorectal cancer, and metabolic dysfunction-associated steatohepatitis (MASH) are being developed with increasing speed and precision. Yet for many community-based practices, participating in that research remains a significant challenge.

Jun 5, 2025, 15:19 by

Leading oncology research organization adopts Veeva Clinical Platform to enhance study delivery.

Jun 5, 2025, 15:19 by

Jun 5, 2025, 15:19 by

Jun 5, 2025, 15:19 by

CluePoints, the premier sponsor of RBQMLive and provider of leading statistical and AI-driven software solutions, has announced the full agenda and expert speaker line up for the 4th annual, award-winning event, RBQMLive.

Jun 4, 2025, 01:00 by User Not Found

Clinical Research News | California Institute of Technology researchers have successfully transitioned their innovative "smart bandage" technology from preclinical animal studies to human clinical testing, marking a significant milestone in the development of real-time wound monitoring systems for chronic wound management.

Jun 3, 2025, 01:00 by User Not Found

Clinical Research News | A small not-for-profit organization has set itself up as a model for turning the nitty-gritty of scientific research into a metaphorical “black swan event” with major impact on the lives of patients living with an incurable disease. The overarching strategy of the International Myeloma Foundation (IMF) is to function as the convener of the broader myeloma community in ways that lead to improved outcomes for patients in terms of both their quality and quantity of life.

Jun 2, 2025, 10:36 by

IAG (imaging CRO) and Picture Health (AI biomarker platform) just announced a partnership to advance the use of AI-driven imaging biomarkers in oncology trials. This partnership brings together IAG’s expertise and its DYNAMIKA™ AI platform with Picture Health’s Px™ platform and multimodal AI biomarkers. Together, they aim to deliver: Faster insights Smarter patient stratification Earlier, more in-depth reads into oncology treatment outcomes Both companies are women-led, AI-driven, and deeply committed to reshaping clinical research through advanced imaging analytics.

May 30, 2025, 01:00 by User Not Found

Clinical Research News | PhaseV intends to grow its vertical AI platform to provide holistic solutions for clinical development; Carta Healthcare is expanding to meet the surging demands among health systems and life sciences organizations for AI-driven innovation that can transform clinical data into valuable insights; and more.